Astec LifeSciences Limited
NSE: ASTECINE563J01010·Chemicals·www.godrejastec.com ↗·Mcap ₹1,688 Cr·Listed 2009
₹739.00▲ ₹10.20  (1.40%)
52W: ₹513 – ₹942 · Vol: 1.1L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19Q3 FY19Q2 FY19Q1 FY19Q4 FY18
Revenue from operations83.615912573.791.112093.998.569.415450.81111431271172002721731031291721161551121811251407713411911365.5128
Other income0.72.60.81.10.50.81.920.920.911.72.63.846.820.90.81.53.31.81.35.23.91.80.95.83.11.901.8
Total expenses10316913999.212513612113913215783.912915613612017922014291.311214110813391.514611313479.611910796.763103
EBITDA−0.79.24−6.7−115.5−5.7−19.7−46.312.7−18.3−3.43.15.412.133.365.542.921.124.738.215.629.528.342.720.815.36.423.121.223.59.231.2
EBITDA margin-0.8%5.8%3.2%-9.1%-12.1%4.6%-6.1%-20.0%-66.7%8.3%-36.1%-3.1%2.2%4.3%10.3%16.7%24.1%24.7%20.6%19.2%22.2%13.4%19.0%25.3%23.6%16.7%10.9%8.3%17.3%17.8%20.8%14.0%24.3%
Finance costs7.77.97.28.41110.49.99.376.76.166.56.45.94.53.32.61.71.511.11.11.52.13.43.63.53.23.62.92.72.3
Depreciation11.111.811.210.411.511.611.411.59.398.79.29.47.88.88.210.69.18.26.56.56.56.36.36.15.85.75.65.55.44.544
Profit before tax−18.7−7.9−15.7−24.4−33−15.7−25.1−38.5−61.6−0.9−32.2−17.6−11−6.21.224.658.333.212.217.432.211.323.921.739.615.67.8−1.720.215.317.92.426.7
Tax−0−0.20000.415.20−21.90−7.9−4.2−2.8−1.20.46.315.28.53.14.48.24.265.68.53.42.5−0.67.55.36.319.5
Net profit−18.7−7.7−15.7−24.4−33−16.1−40.4−38.5−39.7−1−24.3−13.4−8.2−50.818.343.124.89.113247.117.916.231.212.25.3−1.112.71011.61.517.2
Net margin-22.4%-4.9%-12.6%-33.1%-36.3%-13.5%-43.0%-39.1%-57.2%-0.6%-47.9%-12.1%-5.7%-3.9%0.7%9.2%15.8%14.3%8.8%10.1%13.9%6.1%11.5%14.5%17.3%9.7%3.8%-1.4%9.5%8.4%10.3%2.3%13.4%
EPS (₹)-8.40-3.48-7.04-11.35-16.85-8.20-20.59-19.66-20.260.50-12.41-6.85-4.18-2.540.439.3421.9712.634.636.6312.243.619.128.2715.946.222.70-0.576.505.105.920.088.78
Net profit YoY+43.4%+51.8%+61.1%+36.7%+16.8%−1568.1%−65.9%−187.4%−385.2%+80.6%−2971.0%−173.2%–−111.6%−96.6%+101.8%+79.7%+250.4%−49.2%−19.7%−23.1%−41.9%+237.7%+1558.1%+145.0%+21.9%−54.3%−174.7%−26.0%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19FY18
Revenue from operations448381458628677555523431371
Other income5.15.65.613.110.57.911.911.28.1
Total expenses532528526606566474473386327
EBITDA−4.5−66.2−5.976.315411285.276.568.8
EBITDA margin-1.0%-17.4%-1.3%12.1%22.8%20.1%16.3%17.7%18.6%
Finance costs34.536.725.220.79.14.812.612.410.7
Depreciation44.943.736.333.734.425.723.219.314.7
Profit before tax−81−141−61.734.912189.161.455.955.7
Tax−0.1−6.3−14.99.431.22413.820.120.7
Net profit−80.9−135−46.925.689.965.147.535.835
Net margin-18.0%-35.3%-10.2%4.1%13.3%11.7%9.1%8.3%9.4%
EPS (₹)-37.79-68.71-23.9313.0445.8733.2324.2918.2817.88
Net profit YoY+40.0%−187.3%−283.2%−71.5%+38.1%+36.9%+32.9%+2.1%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow−80.7−8.410.274.723.6
Investing cash flow−4.3−15.2−135−113−104
Financing cash flow94.523.712537.880.5
Capital expenditure5.521.8135117104
Free cash flow (CFO − capex)−86.2−30.2−125−42.6−80.4

Net profit trend

annual, ₹ crore
FY21
₹65.1
FY22
₹89.9+38%
FY23
₹25.6−72%
FY24
₹−46.9−283%
FY25
₹−135−187%
FY26
₹−80.9+40%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated31 Jul 2026PDF on NSE XBRL
Q1 FY27Standalone31 Jul 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited27 Apr 2026 PDF XBRL
Q4 FY26Standalone · audited27 Apr 2026 PDF XBRL
Q3 FY26Consolidated30 Jan 2026PDF on NSE XBRL
Q3 FY26Standalone30 Jan 2026PDF on NSE XBRL
Q2 FY26Consolidated29 Oct 2025PDF on NSE XBRL
Q2 FY26Standalone29 Oct 2025PDF on NSE XBRL
Q1 FY26Consolidated28 Jul 2025PDF on NSE XBRL
Q1 FY26Standalone28 Jul 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 119.7×-24.7×
P/B5Y avg 6.70×4.22×
ROEFY26, on average equity-25.9%
Net margin-18.0%
Debt / equity1.15×
Revenue CAGR (3Y)-10.6%
Profit CAGR (3Y)–
EPS (TTM)₹-29.87
Market cap₹1,647 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
4.22×
vs 8-point avg 6.70× (−37%)
3.08× low6.70× avg9.67× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹942 Cr+7%
Net worth₹391 Cr+66%
Total borrowings₹449 Cr−19%
Cash & bank balances₹10 Cr+1646%
Investments₹0 Cr+0%
Inventories₹138 Cr−14%
Trade receivables₹248 Cr+68%
Trade payables₹88 Cr+7%
Change vs the same date a year earlier.
Revenue mix FY25
Outside India68.4%result ₹0 Cr
Within India31.6%result ₹0 Cr
Segment revenue as reported, before inter-segment eliminations.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jul 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23
Promoter71.9671.9771.9772.4272.4270.8770.8766.7566.7566.7566.7566.75
FII0.010.020.040.000.020.020.251.200.531.031.251.28
DII3.333.343.174.014.014.264.345.414.513.387.889.74
of which MF3.023.023.024.014.013.98––––––
Retail20.4820.8120.8719.3218.9619.9819.6220.7121.9422.5219.6318.19
Other public4.223.863.954.254.594.874.925.936.276.324.494.04
19,889 shareholders · NSE shareholding pattern filings.